2025 Degenerative Disc Disease Treatment 
OrthoSpineNews
JUNE 18, 2025
BALTIMORE, June 18, 2025 -( BUSINESS WIRE )- ReGelTec Inc. , The HYDRAFIL System is an outpatient procedure offering interventional pain physicians and patients a new treatment designed to reduce pain and improve daily function without the need for an invasive surgery. The patient was enrolled by Kas Amirdelfan, M.D., Jasper, Ga.;
OrthoSpineNews
APRIL 1, 2025
Our goal is to move spine surgery beyond the limits of legacy systems, reimagining treatment processes to make them safer, more efficient, and more effective for every patient. 2025) 196:123812. Key Study Findings: 3.4x lower rate of screw loosening (2.7% after one year 3.4 times lower than the 9.2% rate seen in the control group.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
OrthoSpineNews
JULY 10, 2025
OREM, Utah, July 10, 2025 /PRNewswire/ — Dymicron ® , a privately held medical device company pioneering advanced spinal technologies, today announced that the United States (U.S.) spine centers, with the first implantations expected in Q4 2025. Dymicron’s Triadyme-C achieves critical milestone to begin U.S.
OrthoSpineNews
MAY 13, 2025
May 13, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. We intend that the product will be used for the non-surgical treatment of painful lumbosacral disc disorders or as a complementary therapeutic to a surgical procedure. MELVILLE, N.Y.,
OrthoSpineNews
MARCH 3, 2025
Spine Surgeon Dr. Frank Phillips Joins SST Board of Directors SAN ANTONIO, March 3, 2025 /PRNewswire/ — Spinal Stabilization Technologies, LLC (SST) has announced a significant milestone in its mission to revolutionize spinal care: the enrollment of the first U.S. Pierce Nunley completes the first U.S. PerQdisc Surgery.
OrthoSpineNews
JUNE 25, 2025
First in the Nation to Perform Custom Combination of prodisc® C Nova and prodisc® C VIVO Disc Replacement. June 25, 2025 /PRNewswire/ — VSI® proudly announces a groundbreaking achievement in spine surgery, led by nationally recognized spine surgeon Dr. Ehsan Jazini. RESTON, Va.,
OrthoSpineNews
JULY 29, 2025
Data readout expected in Q1 2026 MIAMI, July 29, 2025 (GLOBE NEWSWIRE) — Vivex Biologics, Inc., This achievement reflects the dedication of our clinical teams and strong engagement from the spine care community, underscoring the need for innovative, minimally invasive treatment options for DDD.
Expert insights. Personalized for you.
Let's personalize your content